In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates (Q28538658)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 2014)

edit

Language	Label	Description	Also known as
English	In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates	scientific article (publication date: 2014)

Statements

instance of

scholarly article

0 references

title

In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates (English)

0 references

main subject

antibody

1 reference

based on heuristic

inferred from title

author name string

Dowdy Jackson

series ordinal

1

0 references

John Atkinson

series ordinal

2

0 references

Claudia I Guevara

series ordinal

3

0 references

Chunying Zhang

series ordinal

4

0 references

Vladimir Kery

series ordinal

5

0 references

Sung-Ju Moon

series ordinal

6

0 references

Cyrus Virata

series ordinal

7

0 references

Peng Yang

series ordinal

8

0 references

Christine Lowe

series ordinal

9

0 references

Jason Pinkstaff

series ordinal

10

0 references

Ho Cho

series ordinal

11

0 references

Nick Knudsen

series ordinal

12

0 references

Anthony Manibusan

series ordinal

13

0 references

Feng Tian

series ordinal

14

0 references

Ying Sun

series ordinal

15

0 references

Yingchun Lu

series ordinal

16

0 references

Aaron Sellers

series ordinal

17

0 references

Xiao-Chi Jia

series ordinal

18

0 references

Ingrid Joseph

series ordinal

19

0 references

Banmeet Anand

series ordinal

20

0 references

Kendall Morrison

series ordinal

21

0 references

Daniel S Pereira

series ordinal

22

0 references

David Stover

series ordinal

23

0 references

language of work or name

English

0 references

publication date

2014

0 references

published in

PLOS One

0 references

volume

9

0 references

issue

1

0 references

page(s)

e83865

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

14 January 2014

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

19 March 2017

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

19 March 2017

Water-soluble organocatalysts for hydrazone and oxime formation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

Resistance to HER2-targeted therapy: mechanisms of trastuzumab resistance and possible strategies to overcome unresponsiveness to treatment

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

29 September 2017

Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3891645

retrieved

3 June 2018

Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083865

retrieved

21 January 2018

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083865

retrieved

21 January 2018

Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083865

retrieved

21 January 2018

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24454709

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24454709

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PONE.0083865

0 references

ADS bibcode

2014PLoSO...983865J

0 references

PMC publication ID

3891645

0 references

PubMed publication ID

24454709

0 references

ResearchGate publication ID

259879386

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28538658&oldid=1863034099"